Welsh, Carson, Anderson & Stowe and Hg Combine MMIT and Evaluate to Form Global Pharma Commercial Intelligence Provider

MMIT/Evaluate Acquires Panalgo to Enhance Pharma Analytics Platform

September 28, 2021

Data & Analytics

Managed Markets Insight & Technology (MMIT) and Evaluate (a WCAS and Hg portfolio company) have acquired Panalgo, a healthcare data analytics firm, and will integrate Panalgo's Instant Health Data (IHD) software into the combined MMIT/Evaluate commercialization platform. The acquisition aims to accelerate real-world evidence and market-access analytics capabilities for biopharma, medical device and CRO customers; Silversmith Capital Partners and Transformation Capital (prior Panalgo investors) will remain investors in the combined company.

Welsh, Carson, Anderson & Stowe Commits $250M to Kiniciti Platform for Cell & Gene Therapy Ecosystem

February 1, 2021

Biotechnology

Welsh, Carson, Anderson & Stowe (WCAS) committed up to $250 million to a strategic partnership with newly-formed Kiniciti, a platform that will invest in non-therapeutic companies supporting the cell and gene therapy ecosystem. The capital will support Kiniciti's flexible investment model (control, growth equity and significant minority stakes) to scale companies that provide process, production, materials and delivery capabilities for CGT.

Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters

November 9, 2021

Pharmaceuticals

Welsh, Carson, Anderson & Stowe (WCAS) acquired a majority ownership stake in Leiters, an FDA-registered 503B outsourced pharmaceutical compounding provider. WCAS invested alongside health system investors including Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures and UNC Health, while existing investors — including Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors and H.I.G. BioHealth Partners — made reinvestments to support Leiters' growth, facility expansion and new product development.

Welsh, Carson, Anderson & Stowe Acquires Green Street Advisors from Golden Gate Capital

June 3, 2019

Data & Analytics

Welsh, Carson, Anderson & Stowe (WCAS) has signed a definitive agreement to acquire Green Street Advisors from Golden Gate Capital. Management will reinvest and WCAS plans to accelerate organic growth, invest in product innovation and pursue strategic M&A to expand Green Street's research, data and analytics offerings for the commercial real estate market.

Welsh, Carson, Anderson & Stowe Makes Strategic Growth Investment in ImageTrend, Inc.

February 10, 2023

Software

Welsh, Carson, Anderson & Stowe (WCAS) made an equity growth investment in ImageTrend, Inc., a market-leading provider of public safety and healthcare software, to accelerate growth and product innovation. WCAS partners with ImageTrend’s management and will add investment team members to the board to support continued expansion of the company’s software, analytics, and services across EMS, hospitals, fire, and public safety end markets.

Welsh, Carson, Anderson & Stowe Acquires Majority Stake in GovernmentCIO

November 2, 2020

IT Services

Welsh, Carson, Anderson & Stowe (WCAS) completed a strategic majority investment in GovernmentCIO, a provider of technology and digital solutions to the federal health IT market. The investment will fund organic growth and support a buy-and-build strategy to expand GovernmentCIO’s capabilities and customer footprint across federal health and adjacent federal IT markets.